Fungal biofilm related infections are commonly associated with medical devices with
biofilms contributing to the virulence of the involved fungal species. If infection does occur …

Pathogenic fungi have the capacity to form tenacious biofilm structures that are notoriously
unresponsive to antifungal therapies. Fungal biofilms are ubiquitous, located all over the …

Fungal biofilms are highly resilient to antifungal therapies, of which there are relatively few
licensed options available in clinical medicine. Nonetheless, there is a vibrant research …

Biofilms cause recurrent invasive infections that are difficult to eradicate because of their
high resistance to antimicrobials and host defence mechanisms. Fungal biofilm-related …

Fungal biofilms have become an increasingly important clinical problem. The widespread
use of antibiotics, frequent use of indwelling medical devices, and a trend toward increased …

Fungal biofilms are an escalating clinical problem associated with significant rates of
mortality. Candida albicans is the most notorious of all fungal biofilm formers. However, non …

The current understanding of the fungal biofilm is that it is a complex community of
microorganisms capapable of surviving and thriving in a multitude of environments. Its ability …

Fungal infections constitute a major threat for an expanding population of
immunosuppressed patients, as these infections carry unacceptably high morbidity and …

The past decades have witnessed a dramatic increase in invasive fungal infections,
especially caused by different species belonging to the Candida genus. Nowadays, even …

Background: The treatment of wound-associated infections has always remained a
challenge for clinicians, with the major deterring factor being microbial biofilms, majorly …